Clinical trials for lung cancer
130 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial

Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Targeted therapy
Systemic Treatment-Naive
Janssen
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
ALK
None
Systemic Treatment-Naive
Surgery
Hoffmann-La Roche
Hoffmann-La Roche
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
ALK
EGFR
Bristol-Myers Squibb
Bristol-Myers Squibb
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
AstraZeneca
Phase 3
Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
RET
ROS-1
Systemic Treatment-Naive
Car-T
Hôpital Privé du Confluent - Vivalto Santé (Nantes), Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire Angers (Angers )
Genmab
Phase 3
Lung cancer
#NCT06312137
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
ALK
Clinique Teissier - Valenciennes (Valenciennes), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Tenon AP-HP (Paris ), Hôpital Larrey (Toulouse ), Hôpital Louis Pradel (Bron ) (and 4 more...)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06345729
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
KRAS G12C
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
Immunotherapy
Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), Centre hospitalier universitaire François Mitterrand (Dijon), Clinique Teissier - Valenciennes (Valenciennes), Centre Jean Perrin (Clermont Ferrand )
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06417814
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
EGFR
Targeted therapy
Chemotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Centre de Cancérologie du Grand Montpellier (Montpellier), Institut Sainte Catherine (Avignon), Hôpital d'Instruction des Armées Sainte-Anne (Toulon), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers )
AstraZeneca